# Quantitative 13N-Ammonia Cardiac Rest/Stress Digital PET/CT

> **NCT03170817** · — · COMPLETED · sponsor: **Stanford University** · enrollment: 15 (actual)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DIAGNOSTIC_TEST:** Cardiac Perfusion Rest/Stress Digital PET/CT
- **DRUG:** N-13 ammonia
- **DRUG:** Regadenoson

## Key facts

- **NCT ID:** NCT03170817
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-03-29
- **Primary completion:** 2020-03-31
- **Final completion:** 2021-09-01
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2021-10-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03170817

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03170817, "Quantitative 13N-Ammonia Cardiac Rest/Stress Digital PET/CT". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03170817. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*